Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) FCF Margin (2023 - 2024)

Praxis Precision Medicines (PRAX) has 2 years of FCF Margin data on record, last reported at 752.0% in Q4 2024.

  • For Q4 2024, FCF Margin rose 388120.0% year-over-year to 752.0%; the TTM value through Sep 2025 reached 3067.41%, up 313172.0%, while the annual FY2024 figure was 1540.48%, 300329.0% up from the prior year.
  • FCF Margin reached 752.0% in Q4 2024 per PRAX's latest filing, up from 9105.96% in the prior quarter.
  • Across five years, FCF Margin topped out at 752.0% in Q4 2024 and bottomed at 9105.96% in Q3 2024.